Publications by authors named "Bo-le Liu"
A 55-year-old man with cough, bone pain, and cervical lymphadenopathy underwent both 18F-FDG and 18F-PSMA-1007 PET/CT scans with clinical suspicion of malignant disease. Compared with 18F-FDG PET/CT, 18F-PSMA PET/CT showed intense tracer uptake in the prostate gland, lungs, osteogenic lesions, and multiple lymph nodes. Interestingly, we also found the high tracer concentration of pulmonary lymphangitic carcinomatosis, a very rare form of prostate cancer metastasis to the lung, on 18F-PSMA-1007 PET/CT images.
View Article and Find Full Text PDFBackground: Evidence regarding the relationship between fluorodeoxyglucose (FDG) uptake in the bone marrow of patients with lung adenocarcinoma and prognosis is limited. This study aimed to identify whether bone marrow FDG uptake is a risk factor for recurrence in patients after curative surgical resection of T1-2N0M0 lung adenocarcinoma.
Methods: From January 2012 to December 2016, we retrospectively enrolled 195 pT1-2N0M0 lung adenocarcinoma patients who underwent both preoperative FDG positron emission tomography/computed tomography (PET/CT) and surgical resection from the lung adenocarcinoma database maintained by the PET/CT department at our hospital.
Article Synopsis
- This study explores the effectiveness of F-PSMA-1007 PET/CT as a tool for assessing non-metastatic high-risk prostate cancer (PCa) in 101 patients classified based on risk levels according to European guidelines.
- The research finds a significant correlation between the maximum standardized uptake values (SUVmax) of the primary tumor, prostate-specific antigen (PSA) levels, and Gleason scores (GS), with higher SUVmax associated with more aggressive tumors.
- The optimal SUVmax cutoff for identifying high-risk PCa was determined to be 9.05, indicating high sensitivity and moderate specificity as a diagnostic marker.